970*90
768
468
mobile

Aurobindo Pharma to acquire product under development & related assets from Advent Pharmaceuticals

Franchise India Bureau
Franchise India Bureau Nov 14 2018 - 0 min read
Aurobindo Pharma to acquire product under development & related assets from Advent Pharmaceuticals
This acquisition will help Aurobindo to boost its research and development capabilities in complex speciality generics.

Aurobindo Pharma Ltd, a Hyderabad-based drugmaker, will acquire a product under development and related assets from Australia-based Advent Pharmaceuticals Pty Ltd for $12.5 million in cash.

The deal is expected to close by January 2019. This acquisition will help Aurobindo to boost its research and development capabilities in complex speciality generics.

Advent Pharmaceuticals is a speciality research and development company, which focuses on generic inhaled products for global markets.

Subscribe Newsletter
Submit your email address to receive the latest updates on news & host of opportunities
Entrepreneur Magazine

For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you

or Click here to Subscribe Online